
Report on the Annual Global Survey 2025
The Report on Annual Global Survey includes demographic and treatment data, providing a global snapshot of people with hemophilia, von
Year:
Language: English
Author(s): World Federation of Hemophilia
Format: Video
This session from the WFH 2020 Virtual Summit was developed as an educational response to the COVID-19 pandemic for the global bleeding disorders community. Speakers Radoslaw Kaczmarek, Flora Peyvandi, Cedric Hermans and Mark Skinner discuss the pathophysiology and clinical manifestations of COVID-19, practical advice on the management of COVID-19, and safety and supply of plasma derived products during the pandemic.
The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.
The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.

The Report on Annual Global Survey includes demographic and treatment data, providing a global snapshot of people with hemophilia, von

Explore the science behind genetic technologies for hemophilia in this four-part video series from the WFH. Learn the basics of

This booklet contains basic information about psychosocial aspects of rare coagulation factor deficiencies. This resource was developed by members of

This booklet contains basic information about psychosocial aspects of rare coagulation factor deficiencies. This resource was developed by members of

This booklet contains basic information about psychosocial aspects of rare coagulation factor deficiencies. This resource was developed by Silvina Graña

A summary of discussions held at the Fourteenth WFH Global Forum on Advances and Access to Safe Treatment Products for